Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST)

OBJECTIVE: The aim was to report results from PERSIST, a real-life, observational, prospective cohort study of CT-P13, an infliximab (IFX) biosimilar, for treatment of patients with RA, AS or PsA who were biologic naïve or switched from an IFX reference product (IFX-RP; Remicade). METHODS: Adult pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Peter C, Christensen, Robin, Moosavi, Shahrzad, Selema, Pamela, Guilatco, Ruffy, Fowler, Heather, Mueller, Markus, Liau, Katherine F, Haraoui, Boulos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346696/
https://www.ncbi.nlm.nih.gov/pubmed/34377890
http://dx.doi.org/10.1093/rap/rkab026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346696/
https://www.ncbi.nlm.nih.gov/pubmed/34377890
http://dx.doi.org/10.1093/rap/rkab026

Ejemplares similares